This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Talk Therapy After Stroke (PS-POST AVC)

This study has been terminated.
Information provided by (Responsible Party):
Centre Hospitalier Universitaire de Nice Identifier:
First received: February 20, 2012
Last updated: October 30, 2015
Last verified: December 2010
Strokes are the first cause of acquired physical disability among adults. Some studies proved that depression is often an unrecognized complication from stroke, associated with a vital prognosis, functional and cognitive pejorative diagnosis. It led us to pose the hypothesis of the existence of a particular psychological state after stroke particularly favorable to a psychotherapeutic alliance. So, this longitudinal monocentric study aims to estimate the feasibility of a talk therapy and its impact on the anxio-depressive symptomatology after stroke.

Condition Intervention
Adams-Stokes Syndrome Behavioral: talk therapy

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Talk Therapy After Stroke. PS-POST AVC

Further study details as provided by Centre Hospitalier Universitaire de Nice:

Primary Outcome Measures:
  • acceptability [ Time Frame: at 6 months ]
    Participation rate in the study

Secondary Outcome Measures:
  • Rates of anxiety and depression [ Time Frame: at 3 and 6 months ]
    Montgomery and Asberg Depression Rating Scale(depressive patients) and wide COVI (anxious patients)

  • Evaluation of quality of life [ Time Frame: at 3 and 6 months ]
    MM20-QOL scale

  • Evaluation of functional recovery [ Time Frame: at 3 and 6 months ]
    • Barthel index and Rankin score
    • NIHSS score

  • Assessment of apathy [ Time Frame: at 3 and 6 months ]
    apathy index

  • Categorization of patients [ Time Frame: 6 months ]
    according to their pattern of coping with specific scales and RWCQ (Revised Ways of Coping Questionnaire - stroke modified version) QSSP (Questionnaire de soutien social perçu)

Enrollment: 2
Study Start Date: February 2011
Study Completion Date: March 2013
Primary Completion Date: May 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Talk therapy
A cohort of 25 patients
Behavioral: talk therapy


Ages Eligible for Study:   18 Years to 85 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • ischemic or aemoragic stroke minor 1 week, confirmed by cerebral imaging

Exclusion Criteria:

  • severe aphasia (NIHSS criteria 9: sup or egal: 2)
  • Chronic psychiatric preexistant desease.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01630005

CHU Nice
Nice, France, 06200
Sponsors and Collaborators
Centre Hospitalier Universitaire de Nice
Study Director: Hélène MAHAGNE, PH CHU de Nice
  More Information

Responsible Party: Centre Hospitalier Universitaire de Nice Identifier: NCT01630005     History of Changes
Other Study ID Numbers: 2010-A00905-34
Study First Received: February 20, 2012
Last Updated: October 30, 2015

Additional relevant MeSH terms:
Adams-Stokes Syndrome
Heart Block
Arrhythmias, Cardiac
Heart Diseases
Cardiovascular Diseases
Pathologic Processes processed this record on June 23, 2017